Synergistic anti-tumor effects of lenalidomide and gefitinib by upregulating ADRB2 and inactivating the mTOR/PI3K/AKT signaling pathway in lung adenocarcinoma
S Zhou, M Deng, X Bian, J Shi, R Liang… - Cellular and Molecular …, 2024 - cellmolbiol.org
Gefitinib is commonly used to be the first-line therapy for advanced non-small cell lung
cancer (NSCLC). Therapeutic effect of gefitinib is reduced due to acquired resistance, and …
cancer (NSCLC). Therapeutic effect of gefitinib is reduced due to acquired resistance, and …
The differential expression of AFF3 in cervical cancer and its correlation with clinicopathological features and prognosis
Y Zhang, L Li, Q Han, L Wen - Journal of Obstetrics and …, 2024 - Taylor & Francis
Background Cervical cancer (CC) is the second most common malignancy in women, and
identifying biomarkers of CC is crucial for prognosis prediction. Here, we investigated the …
identifying biomarkers of CC is crucial for prognosis prediction. Here, we investigated the …